HRP20010238B1 - 2-methyl-thieno-benzodiazepine formulation - Google Patents

2-methyl-thieno-benzodiazepine formulation

Info

Publication number
HRP20010238B1
HRP20010238B1 HR20010238A HRP20010238A HRP20010238B1 HR P20010238 B1 HRP20010238 B1 HR P20010238B1 HR 20010238 A HR20010238 A HR 20010238A HR P20010238 A HRP20010238 A HR P20010238A HR P20010238 B1 HRP20010238 B1 HR P20010238B1
Authority
HR
Croatia
Prior art keywords
thieno
methyl
benzodiazepine formulation
benzodiazepine
formulation
Prior art date
Application number
HR20010238A
Other languages
English (en)
Croatian (hr)
Inventor
Harry Ferguson Thomas
Arthur Bunnell Charles
Arnold Hendriksen Barry
Vicente Sanchez-Felix Manuel
Edward Tupper David
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HRP20010238A2 publication Critical patent/HRP20010238A2/hr
Publication of HRP20010238B1 publication Critical patent/HRP20010238B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20010238A 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepine formulation HRP20010238B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation
PCT/US1999/006417 WO2000018408A1 (en) 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepine formulation

Publications (2)

Publication Number Publication Date
HRP20010238A2 HRP20010238A2 (en) 2002-04-30
HRP20010238B1 true HRP20010238B1 (en) 2006-05-31

Family

ID=26859927

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010238A HRP20010238B1 (en) 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepine formulation

Country Status (28)

Country Link
EP (1) EP1119359B1 (cs)
JP (1) JP4551988B2 (cs)
CN (1) CN1146422C (cs)
AT (2) ATE359793T1 (cs)
AU (1) AU759751B2 (cs)
BR (1) BR9914156A (cs)
CA (1) CA2344873A1 (cs)
CZ (1) CZ302367B6 (cs)
DE (2) DE69935873T2 (cs)
DK (2) DK1119359T3 (cs)
EA (1) EA002580B1 (cs)
ES (2) ES2285294T3 (cs)
GE (1) GEP20094818B (cs)
HK (1) HK1041199B (cs)
HR (1) HRP20010238B1 (cs)
HU (1) HU227400B1 (cs)
ID (1) ID29574A (cs)
IL (2) IL141766A0 (cs)
MY (1) MY126476A (cs)
NO (1) NO328243B1 (cs)
NZ (1) NZ510208A (cs)
PL (1) PL196821B1 (cs)
PT (2) PT1119359E (cs)
SK (1) SK285944B6 (cs)
TR (1) TR200100885T2 (cs)
TW (1) TW577890B (cs)
UA (1) UA66872C2 (cs)
WO (1) WO2000018408A1 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
AU779452B2 (en) * 1999-12-28 2005-01-27 Cipla Limited New polymorphic forms of olanzapine
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
WO2006006185A1 (en) * 2004-07-14 2006-01-19 Shasun Chemicals And Drugs Limited Improved process for making form i of olanzapine.
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
KR20130030305A (ko) * 2004-11-16 2013-03-26 엘란 파마 인터내셔널 리미티드 주사가능한 나노입자형 올란자핀 제형
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
PT1838716E (pt) * 2005-01-05 2011-07-15 Lilly Co Eli Di-hidrato de pamoato de olanzapina
CZ299218B6 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
JP5486690B2 (ja) * 2009-11-16 2014-05-07 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ メラノコルチン受容体リガンドの医薬組成物
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
CN107625728A (zh) 2010-10-18 2018-01-26 大日本住友制药株式会社 注射用缓释制剂
WO2014125500A1 (en) 2013-02-13 2014-08-21 Neuland Laboratories Limited A process for preparation of olanzapine pamoate
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
US10646443B2 (en) 2017-03-20 2020-05-12 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095499A1 (en) * 1992-05-08 1993-11-09 Petrus J. M. Van Den Oetelaar Depot preparation
ATE188375T1 (de) * 1992-11-17 2000-01-15 Yoshitomi Pharmaceutical Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
IL128956A0 (en) * 1996-09-23 2000-02-17 Lilly Co Eli Olanzapine dihydrate D
CN1239158C (zh) * 1997-09-30 2006-02-01 伊莱利利公司 2－甲基－噻吩并－苯并二氮杂䓬制剂

Also Published As

Publication number Publication date
PT1119359E (pt) 2004-08-31
ES2221376T3 (es) 2004-12-16
HRP20010238A2 (en) 2002-04-30
PT1468689E (pt) 2007-07-09
ID29574A (id) 2001-09-06
AU759751B2 (en) 2003-05-01
EP1119359A4 (en) 2001-12-19
EP1119359B1 (en) 2004-05-26
NZ510208A (en) 2003-04-29
BR9914156A (pt) 2001-06-26
IL141766A0 (en) 2002-03-10
IL141766A (en) 2006-12-31
ES2285294T3 (es) 2007-11-16
DE69935873D1 (de) 2007-05-31
NO20011583L (no) 2001-03-28
ATE359793T1 (de) 2007-05-15
DE69935873T2 (de) 2008-01-10
HU227400B1 (en) 2011-05-30
CA2344873A1 (en) 2000-04-06
UA66872C2 (uk) 2004-06-15
ATE267602T1 (de) 2004-06-15
CN1320038A (zh) 2001-10-31
DE69917663D1 (de) 2004-07-01
SK285944B6 (sk) 2007-11-02
PL346981A1 (en) 2002-03-11
CZ20011149A3 (cs) 2002-01-16
CZ302367B6 (cs) 2011-04-13
CN1146422C (zh) 2004-04-21
AU3362799A (en) 2000-04-17
HUP0103636A3 (en) 2003-05-28
WO2000018408A1 (en) 2000-04-06
EP1119359A1 (en) 2001-08-01
TW577890B (en) 2004-03-01
HK1041199B (en) 2005-03-18
HUP0103636A2 (hu) 2002-01-28
JP2002525330A (ja) 2002-08-13
NO20011583D0 (no) 2001-03-28
EA002580B1 (ru) 2002-06-27
DE69917663T2 (de) 2005-05-25
NO328243B1 (no) 2010-01-11
TR200100885T2 (tr) 2001-08-21
DK1119359T3 (da) 2004-08-16
DK1468689T3 (da) 2007-08-13
HK1041199A1 (en) 2002-07-05
JP4551988B2 (ja) 2010-09-29
EA200100406A1 (ru) 2001-10-22
PL196821B1 (pl) 2008-02-29
GEP20094818B (en) 2009-11-10
MY126476A (en) 2006-10-31
SK4162001A3 (en) 2002-03-05

Similar Documents

Publication Publication Date Title
HRP20000181B1 (en) 2-methyl-thieno-benzodiazepine formulation
HRP20010238B1 (en) 2-methyl-thieno-benzodiazepine formulation
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
DE69800983D1 (de) Verdickte filmbildende Zusammensetzung
ID20053A (id) Hipolipidemat 1,4-benzotiazepin-1,1-dioksida
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
ATE275557T1 (de) 2-substituierte 4,5-diarylimidazole
BR0104326B1 (pt) ôcomposição aquosa de revestimentoö.
TR199800375A3 (tr) Selant kompozisyonlari.
BR9711970A (pt) Derivados 6,5-substitu¡do-heterobic¡clicos
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
EP0679700A3 (en) Aqueous coating composition.
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
BR9915458B1 (pt) formulação antiparasitária tópica.
DE69824822D1 (de) Wässerige Antischaumzusammensetzungen
DE69300694D1 (de) Desinfizierende Zusammensetzungen.
ITRM940002A0 (it) Composizione orale.
TR27961A (tr) Sübstitüe edilmis 1,2,3,4 -tetrahidro-5-nitro-pirimidinler.
DK1015467T3 (da) 6,9-brobundne erythromycinderivater
DE69626754D1 (de) Wässrige, vernetzbare Zusammensetzungen
EP0570884A3 (en) Composition for positive photoresist.
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20180313

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20190324